Suppression of intestinal calcium entry channel TRPV6 by OCRL, a lipid phosphatase associated with Lowe syndrome and Dent disease

American Journal of Physiology - Cell Physiology

Volumn 302, Issue 10, 2012, Pages

  Wu, Guojin ^a   Zhang, Wei ^a   Na, Tao ^a   Jing, Haiyan ^a   Wu, Hongju ^b   Peng, Ji Bin ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Oculocerebrorenal syndrome of Lowe; Subtype 6; Transient receptor potential; Vanilloid subfamily

Indexed keywords

CALCIUM CHANNEL; RAB PROTEIN; VANILLOID RECEPTOR 6;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM ABSORPTION; CALCIUM TRANSPORT; CONTROLLED STUDY; DENT DISEASE; GENE MUTATION; GENE PRODUCT; HUMAN; HUMAN TISSUE; HYPERCALCIURIA; INTESTINE FUNCTION; LOWE SYNDROME; MOUSE; NONHUMAN; OOCYTE; PRIORITY JOURNAL; XENOPUS LAEVIS;

ANIMALS; CALCIUM; CALCIUM CHANNELS; DENT DISEASE; FEMALE; GENE KNOCKDOWN TECHNIQUES; INTESTINAL MUCOSA; OCULOCEREBRORENAL SYNDROME; PHOSPHATIDATE PHOSPHATASE; PHOSPHORIC MONOESTER HYDROLASES; PROTEIN BINDING; PROTEIN TRANSPORT; RATS; TRPV CATION CHANNELS; XENOPUS LAEVIS;

XENOPUS LAEVIS;

EID: 84861120905     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00277.2011     Document Type: Article

References (59)

1. Attree O, Olivos IM, Okabe I, Bailey LC, Nelson DL, Lewis RA, McInnes RR, Nussbaum RL. The Lowe's oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphatase. Nature 358: 239-242, 1992.
2. Bianco SD, Peng JB, Takanaga H, Suzuki Y, Crescenzi A, Kos CH, Zhuang L, Freeman MR, Gouveia CH, Wu J, Luo H, Mauro T, Brown EM, Hediger MA. Marked disturbance of calcium homeostasis in mice with targeted disruption of the Trpv6 calcium channel gene. J Bone Miner Res 22: 274-285, 2007.
3. Bothwell SP, Chan E, Bernardini IM, Kuo YM, Gahl WA, Nussbaum RL. Mouse model for Lowe syndrome/Dent disease 2 renal tubulopathy. J Am Soc Nephrol 22: 443-448, 2011.
4. Cho HY, Lee BH, Choi HJ, Ha IS, Choi Y, Cheong HI. Renal manifestations of Dent disease and Lowe syndrome. Pediatr Nephrol 23: 243-249, 2008.
5. Choudhury R, Diao A, Zhang F, Eisenberg E, Saint-Pol A, Williams C, Konstantakopoulos A, Lucocq J, Johannes L, Rabouille C, Greene LE, Lowe M. Lowe syndrome protein OCRL1 interacts with clathrin and regulates protein trafficking between endosomes and the trans-Golgi network. Mol Biol Cell 16: 3467-3479, 2005.
6. Choudhury R, Noakes CJ, McKenzie E, Kox C, Lowe M. Differential clathrin binding and subcellular localization of OCRL1 splice isoforms. J Biol Chem 284: 9965-9973, 2009.
7. Cui M, Fleet J. Transgenic over-expression of human TRPV6 in intestine increases calcium absorption efficiency and improves bone mass in mice (Abstract). J Bone Miner Res 25, Suppl 1: 10-18-2010, 2010. [Available at http://www.asbmr.org/Meetings/AnnualMeeting/AbstractDetail.aspx? Aid?5cc85c32-51fa-465c-af36-e1db4338942d. Accessed 16 Nov, 2010.]
8. Dent CE, Friedman M. Hypercalcuric rickets associated with renal tubular damage. Arch Dis Child 39: 240-249, 1964.
9. Devuyst O, Pirson Y. Genetics of hypercalciuric stone forming diseases. Kidney Int 72: 1065-1072, 2007.
10. Devuyst O, Thakker RV. Dent's disease. Orphanet J Rare Dis 5: 28, 2010.
11. 2 5-phosphatase, is localized to the trans-Golgi network of fibroblasts and epithelial cells. J Histochem Cytochem 48: 179-190, 2000.
12. Erdmann KS, Mao Y, McCrea HJ, Zoncu R, Lee S, Paradise S, Modregger J, Biemesderfer D, Toomre D, De CP. A role of the Lowe syndrome protein OCRL in early steps of the endocytic pathway. Dev Cell 13: 377-390, 2007.
13. Faucherre A, Desbois P, Satre V, Lunardi J, Dorseuil O, Gacon G. Lowe syndrome protein OCRL1 interacts with Rac GTPase in the trans-Golgi network. Hum Mol Genet 12: 2449-2456, 2003.
14. Frick KK, Bushinsky DA. Molecular mechanisms of primary hypercalciuria. J Am Soc Nephrol 14: 1082-1095, 2003.
15. Hoopes RR Jr, Shrimpton AE, Knohl SJ, Hueber P, Hoppe B, Matyus J, Simckes A, Tasic V, Toenshoff B, Suchy SF, Nussbaum RL, Scheinman SJ. Dent disease with mutations in OCRL1. Am J Hum Genet 76: 260-267, 2005.
16. Hou X, Hagemann N, Schoebel S, Blankenfeldt W, Goody RS, Erdmann KS, Itzen A. A structural basis for Lowe syndrome caused by mutations in the Rab-binding domain of OCRL1. EMBO J 30: 1659-1670, 2011.
17. Hyvola N, Diao A, McKenzie E, Skippen A, Cockcroft S, Lowe M. Membrane targeting and activation of the Lowe syndrome protein OCRL1 by rab GTPases. EMBO J 25: 3750-3761, 2006.
18. Janne PA, Suchy SF, Bernard D, MacDonald M, Crawley J, Grinberg A, Wynshaw-Boris A, Westphal H, Nussbaum RL. Functional overlap between murine Inpp5b and Ocrl1 may explain why deficiency of the murine ortholog for OCRL1 does not cause Lowe syndrome in mice. J Clin Invest 101: 2042-2053, 1998.
19. Jefferson AB, Majerus PW. Mutation of the conserved domains of two inositol polyphosphate 5-phosphatases. Biochemistry 35: 7890-7894, 1996.
20. Jiang Y, Cong P, Williams SR, Zhang W, Na T, Ma HP, Peng JB. WNK4 regulates the secretory pathway via which TRPV5 is targeted to the plasma membrane. Biochem Biophys Res Commun 375: 225-229, 2008.
21. Jiang Y, Ferguson WB, Peng JB. WNK4 enhances TRPV5-mediated calcium transport: potential role in hypercalciuria of familial hyperkalemic hypertension caused by gene mutation of WNK4. Am J Physiol Renal Physiol 292: F545-F554, 2007.
22. Johnson JM, Castle J, Garrett-Engele P, Kan Z, Loerch PM, Armour CD, Santos R, Schadt EE, Stoughton R, Shoemaker DD. Genome-wide survey of human alternative premRNA splicing with exon junction microarrays. Science 302: 2141-2144, 2003.
23. Klausner RD, Donaldson JG, Lippincott-Schwartz J. Brefeldin A: insights into the control of membrane traffic and organelle structure. J Cell Biol 116: 1071-1080, 1992.
24. Lloyd SE, Pearce SH, Fisher SE, Steinmeyer K, Schwappach B, Scheinman SJ, Harding B, Bolino A, Devoto M, Goodyer P, Rigden SP, Wrong O, Jentsch TJ, Craig IW, Thakker RV. A common molecular basis for three inherited kidney stone diseases. Nature 379: 445-449, 1996.
25. Lowe CU, Terrey M, MacLachlan EA. Organic-aciduria, decreased renal ammonia production, hydrophthalmos, and mental retardation; a clinical entity. AMA Am J Dis Child 83: 164-184, 1952.
26. Lowe M. Structure and function of the Lowe syndrome protein OCRL1. Traffic 6: 711-719, 2005.
27. Luyckx VA, Leclercq B, Dowland LK, Yu AS. Diet-dependent hypercalciuria in transgenic mice with reduced CLC5 chloride channel expression. Proc Natl Acad Sci USA 96: 12174-12179, 1999.
28. Mao Y, Balkin DM, Zoncu R, Erdmann KS, Tomasini L, Hu F, Jin MM, Hodsdon ME, De CP. A PH domain within OCRL bridges clathrinmediated membrane trafficking to phosphoinositide metabolism. EMBO J 28: 1831-1842, 2009.
29. Meyer MB, Watanuki M, Kim S, Shevde NK, Pike JW. The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cells. Mol Endocrinol 20: 1447-1461, 2006.
30. Na T, Zhang W, Peng JB. Chloride channel ClC-5 linked to Dent's disease decreases protein level of the intestinal calcium entry channel TRPV6 in Xenopus oocytes (Abstract). FASEB J 23: 998.15, 2009.
31. Olivos-Glander IM, Janne PA, Nussbaum RL. The oculocerebrorenal syndrome gene product is a 105-kD protein localized to the Golgi complex. Am J Hum Genet 57: 817-823, 1995.
32. Peng JB, Brown EM, Hediger MA. Structural conservation of the genes encoding CaT1, CaT2, and related cation channels. Genomics 76: 99-109, 2001.
33. Peng JB, Chen XZ, Berger UV, Vassilev PM, Tsukaguchi H, Brown EM, Hediger MA. Molecular cloning and characterization of a channellike transporter mediating intestinal calcium absorption. J Biol Chem 274: 22739-22746, 1999.
34. Peng JB, Chen XZ, Berger UV, Weremowicz S, Morton CC, Vassilev PM, Brown EM, Hediger MA. Human calcium transport protein CaT1. Biochem Biophys Res Commun 278: 326-332, 2000.
35. +-channel disruption impairs endocytosis in a mouse model for Dent's disease. Nature 408: 369-373, 2000.
36. Ponting CP. A novel domain suggests a ciliary function for ASPM, a brain size determining gene. Bioinformatics 22: 1031-1035, 2006.
37. Reinhart SC, Norden AG, Lapsley M, Thakker RV, Pang J, Moses AM, Frymoyer PA, Favus MJ, Hoepner JA, Scheinman SJ. Characterization of carrier females and affected males with X-linked recessive nephrolithiasis. J Am Soc Nephrol 5: 1451-1461, 1995.
38. Ren M, Xu G, Zeng J, De Lemos-Chiarandini C, Adesnik M, Sabatini DD. Hydrolysis of GTP on rab11 is required for the direct delivery of transferrin from the pericentriolar recycling compartment to the cell surface but not from sorting endosomes. Proc Natl Acad Sci USA 95: 6187-6192, 1998.
39. Scheel O, Zdebik AA, Lourdel S, Jentsch TJ. Voltage-dependent electrogenic chloride/proton exchange by endosomal CLC proteins. Nature 436: 424-427, 2005.
40. Scheinman SJ. Nephrolithiasis. Semin Nephrol 19: 381-388, 1999.
41. Shrimpton AE, Hoopes RR Jr, Knohl SJ, Hueber P, Reed AA, Christie PT, Igarashi T, Lee P, Lehman A, White C, Milford DV, Sanchez MR, Unwin R, Wrong OM, Thakker RV, Scheinman SJ. OCRL1 mutations in Dent 2 patients suggest a mechanism for phenotypic variability. Nephron Physiol 112: 27-36, 2009.
42. Silva IV, Cebotaru V, Wang H, Wang XT, Wang SS, Guo G, Devuyst O, Thakker RV, Guggino WB, Guggino SE. The ClC-5 knockout mouse model of Dent's disease has renal hypercalciuria and increased bone turnover. J Bone Miner Res 18: 615-623, 2003.
43. Sliman GA, Winters WD, Shaw DW, Avner ED. Hypercalciuria and nephrocalcinosis in the oculocerebrorenal syndrome. J Urol 153: 1244-1246, 1995.
44. Stenmark H. Rab GTPases as coordinators of vesicle traffic. Nat Rev Mol Cell Biol 10: 513-525, 2009.
45. 2 5-phosphatase, ocrl1. J Inherit Metab Dis 32: 280-288, 2009.
46. 2 5-phosphatase in Lowe syndrome affects actin polymerization. Am J Hum Genet 71: 1420-1427, 2002.
47. Suzuki Y, Pasch A, Bonny O, Mohaupt MG, Hediger MA, Frey FJ. Gain-of-function haplotype in the epithelial calcium channel TRPV6 is a risk factor for renal calcium stone formation. Hum Mol Genet 17: 1613-1618, 2008.
48. Thyagarajan B, Lukacs V, Rohacs T. Hydrolysis of phosphatidylinositol 4,5-bisphosphate mediates calcium-induced inactivation of TRPV6 channels. J Biol Chem 283: 14980-14987, 2008.
49. Tosetto E, Addis M, Caridi G, Meloni C, Emma F, Vergine G, Stringini G, Papalia T, Barbano G, Ghiggeri GM, Ruggeri L, Miglietti N, Angelo D, Melis MA, Anglani F. Locus heterogeneity of Dent's disease: OCRL1 and TMEM27 genes in patients with no CLCN5 mutations. Pediatr Nephrol 24: 1967-1973, 2009.
50. Ungewickell A, Ward ME, Ungewickell E, Majerus PW. The inositol polyphosphate 5-phosphatase Ocrl associates with endosomes that are partially coated with clathrin. Proc Natl Acad Sci USA 101: 13501-13506, 2004.
51. Utsch B, Bokenkamp A, Benz MR, Besbas N, Dotsch J, Franke I, Frund S, Gok F, Hoppe B, Karle S, Kuwertz-Broking E, Laube G, Neb M, Nuutinen M, Ozaltin F, Rascher W, Ring T, Tasic V, van Wijk JA, Ludwig M. Novel OCRL1 mutations in patients with the phenotype of Dent disease. Am J Kidney Dis 48: 942-14, 2006.
52. Van Cromphaut SJ, Dewerchin M, Hoenderop JG, Stockmans I, Van Herck E, Kato S, Bindels RJ, Collen D, Carmeliet P, Bouillon R, Carmeliet G. Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects. Proc Natl Acad Sci USA 98: 13324-13329, 2001.
53. 2+ channels TRPV5 and TRPV6 to the plasma membrane. Mol Cell Biol 26: 303-312, 2006.
54. Vicinanza M, Di CA, Polishchuk E, Santoro M, Di TG, Godi A, Levtchenko E, De Leo MG, Polishchuk R, Sandoval L, Marzolo MP, De Matteis MA. OCRL controls trafficking through early endosomes via PtdIns4,5P-dependent regulation of endosomal actin. EMBO J 30: 4970-4985, 2011.
55. Wang SS, Devuyst O, Courtoy PJ, Wang XT, Wang H, Wang Y, Thakker RV, Guggino S, Guggino WB. Mice lacking renal chloride channel, CLC-5, are a model for Dent's disease, a nephrolithiasis disorder associated with defective receptor-mediated endocytosis. Hum Mol Genet 9: 2937-2945, 2000.
56. Zerial M, McBride H. Rab proteins as membrane organizers. Nat Rev Mol Cell Biol 2: 107-117, 2001.
57. Zhang W, Na T, Wu G, Jing H, Peng JB. Down-regulation of intestinal apical calcium entry channel TRPV6 by ubiquitin E3 ligase Nedd4-2. J Biol Chem 285: 36586-36596, 2010.
58. Zhang X, Jefferson AB, Auethavekiat V, Majerus PW. The protein deficient in Lowe syndrome is a phosphatidylinositol-4,5-bisphosphate 5-phosphatase. Proc Natl Acad Sci USA 92: 4853-4856, 1995.
59. Zhuang L, Peng JB, Tou L, Takanaga H, Adam RM, Hediger MA, Freeman MR. Calcium-selective ion channel, CaT1, is apically localized in gastrointestinal tract epithelia and is aberrantly expressed in human malignancies. Lab Invest 82: 1755-1764, 2002.